Last reviewed · How we verify
NCT05273645: POTTER
PrOgnosis Following Esophageal FisTula FormaTion in Pts Undergoing CathetER Ablation for AF Study
trial in Atrial Fibrillation in 138 participants. Completed in 28 February 2024.
28 February 2023
Quick facts
| Lead sponsor | University of Luebeck |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 138 |
| Start date | 31 March 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 28 February 2024 |
| Sites | 1 location across Germany |
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Atrio-Oesophageal Fistula — all drugs for Atrio-Oesophageal Fistula →
- PVI — all drugs for PVI →
- Catheter Ablation — all drugs for Catheter Ablation →
Sponsor
University of Luebeck
Who can join
Eligibility, any sex, with Atrial Fibrillation or Atrio-Oesophageal Fistula. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pulmonary vein isolation emerged as an effective and safe strategy to treat atrial fibrillation patients. Atrio-oesophageal fistula (AOF) represents a rare but devastating complication of AF ablation procedure. This complication (0.016-0.07%) requires an international effort to allow for better understanding of the factors contributing to its occurrence and the best management strategies. A worldwide, retrospective, multicenter registry focusing on the incidence, diagnosis and management of this complication.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study.
Tilz RR, Schmidt V, Pürerfellner H, Maury P, et al · · 2023 · cited 121× · PMID 37062040 · DOI 10.1093/eurheartj/ehad250 -
Impact of age on the management and prognosis of esophageal fistula after atrial fibrillation ablation-a subanalysis of the worldwide POTTER-AF study.
Popescu SS, Demirtakan ZG, Schmidt V, Pürerfellner H, et al · · 2025 · PMID 41756165 · DOI 10.3389/fcvm.2025.1708499
Verify or expand the search:
- PubMed search for NCT05273645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other University of Luebeck trials
Trials by the same sponsor.
- NCT06598280 — Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation · NA · recruiting
- NCT06493994 — Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry · recruiting
- NCT05846412 — Treatment of Functional Mitral Regurgitation in Patients With Atrial Fibrillation · NA · unknown
- NCT05710822 — QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study · unknown
- NCT05563142 — Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05273645 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Luebeck
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05273645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing